These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10939804)

  • 1. Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia.
    Albitar M; Beran M; O'Brien S; Kantarjian H; Frieriech E; Keating M; Estey E
    Blood; 2000 Jul; 96(1):372-3. PubMed ID: 10939804
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
    Estey E; Thall P; Beran M; Kantarjian H; Pierce S; Keating M
    Blood; 1997 Oct; 90(8):2969-77. PubMed ID: 9376577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
    Strupp C; Gattermann N; Giagounidis A; Aul C; Hildebrandt B; Haas R; Germing U
    Leuk Res; 2003 May; 27(5):397-404. PubMed ID: 12620291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Sweet's syndrome in a neutropenic patient with acute myeloid leukemia, secondary to a RAEB-T, simulating thrombophlebitis.
    Equitani F; Mele L; Rutella S; Belli P; Paciaroni K; Piscitelli R; Pagano L
    Panminerva Med; 1999 Sep; 41(3):261-3. PubMed ID: 10568127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature.
    Anderson CM; Bueso-Ramos CE; Wallner SA; Albitar M; Rosenzweig TE; Koller CA
    Leuk Lymphoma; 1999 Jan; 32(3-4):385-90. PubMed ID: 10037039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
    Viola A; Falco C; D'Elia R; D'Amico MR; Vicari L; Tambaro FP; Correale P; Laudati D; Palmieri S; Ferrara F
    Eur J Haematol; 2007 Jan; 78(1):41-7. PubMed ID: 17042770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory anemia with excess of blasts in transformation: a dying category?
    Germing U; Gattermann N
    Leuk Res; 2001 Dec; 25(12):1095-6. PubMed ID: 11684282
    [No Abstract]   [Full Text] [Related]  

  • 8. MDS--new classification, new problem?
    Brunning RD
    Leuk Res; 2003 Jul; 27(7):567-9. PubMed ID: 12681354
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of myelodysplastic syndromes].
    Aul C; Heyll A; Gattermann N; Schneider W
    Dtsch Med Wochenschr; 1987 Feb; 112(8):309-13. PubMed ID: 3469067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
    Di Giovanni S; Giallonardo P; Costa MP; Carducci P
    Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.
    Breccia M; Latagliata R; Cannella L; Carmosino I; De Cuia R; Frustaci A; Stefanizzi C; Santopietro M; Alimena G
    Leuk Res; 2009 Mar; 33(3):391-4. PubMed ID: 18676015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular extramedullary myeloid cell tumour in children: an Indian study.
    Gujral S; Bhattarai S; Mohan A; Jain Y; Arya LS; Ghose S; Singha U; Kumar R
    J Trop Pediatr; 1999 Apr; 45(2):112-5. PubMed ID: 10341509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplasia and tuberculosis].
    Ugo V; Ramon S; Delmer A; Cadiou M; Marie JP
    Bull Cancer; 1996 Jul; 83(7):548-52. PubMed ID: 8868942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotyping of blasts in refractory anaemia with excess of blasts.
    Oertel J; Kleiner S; Huhn D
    Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects and diagnosis of refractory anemia with excess of blasts].
    Gladysh VV; Turbina NS
    Klin Med (Mosk); 1990 Nov; 68(11):84-7. PubMed ID: 2283827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transformation into the state of Ph1 chromosome negative chronic myelocytic leukemia after 7 months from diagnosis of refractory anemia with excess of blasts].
    Hirota T; Iizuka Y; Takeuchi J; Horikoshi A; Ohshima T; Okayasu M
    Rinsho Ketsueki; 1988 Jun; 29(6):868-73. PubMed ID: 3166498
    [No Abstract]   [Full Text] [Related]  

  • 20. Re-evaluation of refractory anemia with excess blasts in transformation.
    Ohyashiki K; Nishimaki J; Shoji N; Miyazawa K; Kimura Y; Ohyashiki JH
    Leuk Res; 2001 Nov; 25(11):933-9. PubMed ID: 11597728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.